Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

29 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will look at conducting a medium-intense walking program called Walk With Ease with cancer patients age 60 and above who are starting chemotherapy treatment. We will measure how many of these patients complete their participation in this program.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Walking on Fatigue After Chemotherapy in Patients 65 and Older

NCT02191982

Cancer Geriatric Fatigue

COMPLETED NA

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

NCT02167932

Breast Cancer Aging

COMPLETED

Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal Cancer

NCT02191969

Colorectal Cancer Fatigue

COMPLETED NA

Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older

NCT02328313

Breast Cancer Aging Physical Activity

COMPLETED NA

A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy

NCT06280885

Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary purpose of this study is to evaluate the feasibility of implementing a moderate-intensity walking program (Walk With Ease/WWE) among cancer patients, age ≥60 years, as they undergo cytotoxic chemotherapy treatment. Feasibility will be determined based on the rate of participation in the WWE program. As secondary objectives, we will also establish the rate of completion of a number of instruments, including a Geriatric Assessment tool, and other instruments that measure self-reported quality of life (e.g., fatigue, depression, and pain), and self-reported physical activity (PA). Data from these instruments, as well as from serial measurements of a biomarker of aging (p16INK4a) will be explored and used to inform future studies designed to evaluate any relationship between these variables and participation in the WWE program.

We propose a sample (n=30) of cancer patients ≥60 years of age with potentially curable cancer and a diagnosis of Stage I-III breast cancer, Stage I-III lung cancer, or Stage II-III colon cancer, who are about to begin chemotherapy. Participation will be defined as completing the 6-week WWE program. Results from this study will be used in an RO1 application to the National Cancer Institute (NCI) pertaining to PA interventions among cancer patients and the effects of biomarkers on prognosis and survival.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Colon Cancer Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Breast Cancer Patients 60+

Breast Cancer Patients age 60 and older who have histologically confirmed stage I, II or III disease.

Walk With Ease Program

Intervention Type BEHAVIORAL

The primary activity required of study subjects is a 6-week self-directed (non-group) WWE walking program that study participants do at a place and time that is convenient for them. To start the intervention/program, we schedule a brief baseline meeting with study participants to discuss the program, provide the WWE workbook, secure printed informed consent, and complete various questionnaires. Study participants are also asked to maintain a daily walking diary that is provided to them.

The WWE program includes a workbook with strengthening and stretching exercises, basic facts about arthritis and PA, and information on how to individualize the program.

Collect Blood, GA and Other Survey Tools

Intervention Type OTHER

* Geriatric Assessment (GA) (Version 5)
* Functional Assessment of Cancer Therapy-General (FACT)
* Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue36
* Outcome Expectations for Exercise (OEE) scale29
* Self-Efficacy to Manage Arthritis or Joint Pain (ASE/Arthritis Self-Efficacy)
* Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)34,35
* Visual Analog Scales (VAS)

Surveys included in study are listed above. Whole Blood Sample will be collected for p16 analysis.

Lung Cancer Patients 60+

Lung Cancer Patients age 60 and above who have stage I, II or III disease

Walk With Ease Program

Intervention Type BEHAVIORAL

The primary activity required of study subjects is a 6-week self-directed (non-group) WWE walking program that study participants do at a place and time that is convenient for them. To start the intervention/program, we schedule a brief baseline meeting with study participants to discuss the program, provide the WWE workbook, secure printed informed consent, and complete various questionnaires. Study participants are also asked to maintain a daily walking diary that is provided to them.

The WWE program includes a workbook with strengthening and stretching exercises, basic facts about arthritis and PA, and information on how to individualize the program.

Collect Blood, GA and Other Survey Tools

Intervention Type OTHER

* Geriatric Assessment (GA) (Version 5)
* Functional Assessment of Cancer Therapy-General (FACT)
* Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue36
* Outcome Expectations for Exercise (OEE) scale29
* Self-Efficacy to Manage Arthritis or Joint Pain (ASE/Arthritis Self-Efficacy)
* Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)34,35
* Visual Analog Scales (VAS)

Surveys included in study are listed above. Whole Blood Sample will be collected for p16 analysis.

Colon Cancer Patients 60+

Colon cancer patients age 60 and above who have stage II or III disease.

Walk With Ease Program

Intervention Type BEHAVIORAL

The primary activity required of study subjects is a 6-week self-directed (non-group) WWE walking program that study participants do at a place and time that is convenient for them. To start the intervention/program, we schedule a brief baseline meeting with study participants to discuss the program, provide the WWE workbook, secure printed informed consent, and complete various questionnaires. Study participants are also asked to maintain a daily walking diary that is provided to them.

The WWE program includes a workbook with strengthening and stretching exercises, basic facts about arthritis and PA, and information on how to individualize the program.

Collect Blood, GA and Other Survey Tools

Intervention Type OTHER

* Geriatric Assessment (GA) (Version 5)
* Functional Assessment of Cancer Therapy-General (FACT)
* Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue36
* Outcome Expectations for Exercise (OEE) scale29
* Self-Efficacy to Manage Arthritis or Joint Pain (ASE/Arthritis Self-Efficacy)
* Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)34,35
* Visual Analog Scales (VAS)

Surveys included in study are listed above. Whole Blood Sample will be collected for p16 analysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Walk With Ease Program

The primary activity required of study subjects is a 6-week self-directed (non-group) WWE walking program that study participants do at a place and time that is convenient for them. To start the intervention/program, we schedule a brief baseline meeting with study participants to discuss the program, provide the WWE workbook, secure printed informed consent, and complete various questionnaires. Study participants are also asked to maintain a daily walking diary that is provided to them.

The WWE program includes a workbook with strengthening and stretching exercises, basic facts about arthritis and PA, and information on how to individualize the program.

Intervention Type BEHAVIORAL

Collect Blood, GA and Other Survey Tools

* Geriatric Assessment (GA) (Version 5)
* Functional Assessment of Cancer Therapy-General (FACT)
* Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue36
* Outcome Expectations for Exercise (OEE) scale29
* Self-Efficacy to Manage Arthritis or Joint Pain (ASE/Arthritis Self-Efficacy)
* Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM)34,35
* Visual Analog Scales (VAS)

Surveys included in study are listed above. Whole Blood Sample will be collected for p16 analysis.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

WWE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥60 years of age, male or female
* Histologically confirmed Stage I, II or III breast cancer (if the patient has had more than one breast cancer diagnosis, then the most recent diagnosis); Stage I, II or III lung cancer, or Stage II or III colon cancer
* Scheduled to begin a chemotherapy (or concomitant chemoradiotherapy) regimen that will last at least 6 weeks in duration
* English speaking
* IRB approved, signed written informed consent
* Approval from their treating physician to engage in moderate-intensity physical activity
* Patient-assessed ability to walk and engage in moderate physical activity
* Willing and able to meet all study requirements.

Exclusion Criteria

* One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention
* Cancer surgery scheduled within the study period
* Unable to walk or engage in moderate-intensity physical activity

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No